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Abstract  
The use of antibiotic resistance markers is an important tool in the production and 
selection of transgenic plants.  There have been increased concerns about the potential 
horizontal gene transfer (HGT) from transgenic plants to bacteria of medical and 
environmental importance.  Until recently all antibiotic resistance genes used in 
transgenic studies have been bacterial in origin.  An Arabidopsis thaliana ABC 
transporter, Atwbc19, was the first plant gene shown to confer kanamycin resistance 
when overexpressed in transgenic plants.  The Atwbc19 gene was evaluated for its ability 
to transfer antibiotic resistance to Escherichia coli, which are found in the human gut and 
environment.  Simulated HGT was staged by subcloning Atwbc19 under the control of a 
bacterial promoter, genetically transforming the bacteria and assessing if resistance was 
conferred as compared to the same treatment of the E. coli nptII gene.  The nptII gene 
provided greater resistance to kanamycin in E. coli than that of the Atwbc19 gene and was 
significantly different from the no-plasmid control at higher concentrations of kanamycin 
(e.g., over 10 mg L-1) (p < 0.05).  The Atwbc19 gene was not significantly different from 
the no-plasmid control at higher concentrations of kanamycin (e.g., over 25 mg L-1) (p < 
0.05).  E. coli transformed with Atwbc19 conferred little resistance to kanamycin at 100 
mg L-1.   
Results from Northern gel blot analysis indicated that expression levels for nptII 
were similar to that of Atwbc19 for the two concentrations of the antibiotic kanamycin 
tested.  However, there was a slightly apparent decrease in the level of expression for 
Atwbc19 compared to the nptII gene that was most likely the result to the plant codon 
usage of the ABC gene or its large size (over two-fold greater than nptII).  This research 
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supports the use of the Atwbc19 gene in transgenic plants as a selectable marker and 
potential replacement of the nptII gene for kanamycin selection systems.     
 v
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1. Introduction 
Antibiotic resistant markers (ARMs) derived from bacteria are the most 
commonly inserted genes in transgenic plants (Miki and McHugh 2004).  ARMs allow 
for the detection and selection of transformed plants which can then be manipulated to 
acquire transgenes.  The entire marker or a portion of the marker may remain in the final 
commercial product, a concern to those interested in horizontal gene transfer (HGT) of 
antibiotic resistance genes to bacteria.   One of the most frequently used antibiotic 
resistant marker genes used in plant selection is the Escherichia coli K12 transposon Tn5 
neomycin phosphotransferase gene (nptII), also referred to as aminoglycoside-3’-
phosphotransferase II, which is a selectable marker conferring resistance to several 
aminoglycoside antibiotics including kanamycin and neomycin, of bacterial origin 
(Garfinkel et al. 1981), and engineered with plant-specific promoters to facilitate 
expression in plant cells (reviewed in Miki and McHugh 2004).  Although selectable 
markers derived from bacteria have been recognized by many regulatory agencies as safe, 
there have been concerns raised about the potential risks of creating antibiotic-resistant 
pathogens of human health or environmental importance via horizontal gene transfer 
from transgenic plants.  There is evidence that drug resistance is already widespread in 
bacteria as a consequence of overuse in human and veterinary medicine and as animal 
growth promoters (IFT 2006).  There has been much research in the area of gene transfer 
from bacteria to bacteria (Eisen 2000; Beiko et al. 2005; Gogarten and Townsend 2005; 
Thomas and Nielsen 2005); from transgenic plants to soil- or plant-bacteria (Broer et al. 
1996; de Vries and Wackernagel 1998; de Vries and Wackernagel 2001; de Vries and 
Wackernagel 2004; Gebhard and Smalla 1998; Gebhard and Smalla 1999; Kay et al. 
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2002; Kowalchuk et al. 2003; Nielsen et al. 1997; Nielsen et al. 2000; Schluter et al. 
1995; Smalla et al. 2000; Tepfer et al. 2003;) and from transgenic plants to gut 
microorganisms (Chambers et al. 2002; Deni et al. 2005; Duggan et al. 2000).  Detection 
transformation frequencies vary widely between studies (Schluter et al. 1995; Broer et al. 
1996; Nielsen et al. 1997; Gebhard and Smalla 1998; de Vries and Wackernagel 1998) 
and are estimated at low frequencies, 2 × 10-17 (Schluter et al. 1995), 6 × 10-12 (Broer et 
al. 1996), 10-2 (Nielsen et al. 1997), 5.4 × 10-9 (Gebhard and Smalla 1998) and 3.5 × 10-8 
(de Vries and Wackernagel 1998).  With such low detection frequencies, questions still 
remain on the impact and risks HGT (from transgenic plants to bacteria) may have on 
human health and the environment.   
Recent publications raise concerns that HGT between plants and soil 
microorganisms may be underestimated (Heinemann and Traavik 2004).  However, it has 
been argued that the likelihood of a gene transfer event from a transgenic plant to a 
bacterium is rare (Schluter et al. 1995; Broer et al. 1996; Nielsen et al. 1997; Gebhard 
and Smalla 1998; de Vries and Wackernagel 1998).  This argument is based on several 
factors that have the potential to restrict HGT between plants and soil bacteria—
availability of DNA, ability of bacteria to uptake DNA, stabilization of DNA in the 
bacteria, and expression of DNA in the bacteria (Nielsen et al. 1998). The main barriers 
to HGT between species are the ability of the bacteria to uptake plant DNA (competence) 
and establishment or the stabilization of plant DNA (Nielsen et al. 1998).  Several 
bacteria have natural competence, such as Bacillus subtilis and Acinetobacter sp. strain 
BD413 (Lorenz and Wackernagel 1994).  However, competence is only one factor in the 
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ability of genetic exchange; once the DNA is taken up by the bacteria, the DNA must be 
stably maintained (Nielsen et al. 1998).   
There are three mechanisms of gene transfer utilized by bacteria—general 
transduction, conjugation, and transformation.  The most likely mechanism of gene 
transfer from transgenic plants to bacteria is natural transformation (Nielsen et al. 1998; 
Bertolla and Simonet 1999).  Natural transformation is a process by which competent 
bacteria can uptake free DNA (Stuart and Carlson 1986).  This DNA can then either be 
incorporated and stably maintained in the bacterial genome through homologous 
recombination or can form an autonomous replicating element (Smalla et al. 2000).  
There are more than 70 naturally transformable prokaryotic species including many 
found in the soil as well as some of medical importance (de Vries and Wackernagel 
2004).       
There are alternatives to using bacterial derived antibiotic resistance markers in 
transgenic research, such as the production of marker-free plants, which can be more 
difficult and less efficient (Miki and McHugh 2004), the use of reporter genes as visible 
markers (Miki and McHugh 2004), or the use of selectable markers derived from plants 
(Mentewab and Stewart 2005).  The potential barriers bacteria must surpass in order to 
obtain antibiotic resistance from transgenic plants are myriad.  By adding another 
“barrier”, such as the utilization of a plant-derived antibiotic resistance marker, the 
frequency of gene transfer from transgenic plants to bacteria should be even less of a risk.  
Mentewab and Stewart (2005) recently demonstrated that an overexpressed Arabidopsis 
thaliana ABC transporter, Atwbc19 gene, conferred kanamycin resistance to transgenic 
tobacco plants.  Since this marker is endogenous to and presumably ubiquitous in plants, 
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its use in the selection of transgenic plants should be more widely accepted by the public 
and regulators and inherently less risky than bacteria-derived resistance markers for 
several reasons.  First, ABC transporters are ubiquitously found in plants.  There is no 
evidence that the Atwbc19 transporter has been transferred to bacteria during evolution 
(Mentewab and Stewart 2005).  ABC transporters exist in prokaryotes and no database 
searches have yielded any matches with plant-like codon usage patterns (Mentewab and 
Stewart 2005).  Second, this particular ABC transporter is putatively targeted to 
tonoplasts, which are absent in bacterial cells.  Furthermore, Atwbc19 has been shown to 
be highly specific for kanamycin resistance in transgenic plants; it does not confer 
resistance to geneticin, neomycin or other aminoglycoside antibiotics used clinically 
(Mentewab and Stewart 2005).  Atwbc19 is also rather large in size, 2.2 kb, almost 2.75 
times larger than nptII, 0.8 kb, making it less likely to be fully incorporated into the 
bacterial genome.  Finally, unlike bacterial markers, Atwbc19 has plant codon usage, 
which means that if it somehow did find its way into the bacterial genome and under the 
control of a bacterial promoter, it would most likely be expressed at a much lower level 
than that of a bacterial gene such as nptII.   
The objective of this research was to examine the ability of the Atwbc19 gene 
derived from transgenic tobacco to horizontally transfer antibiotic resistance to bacteria 
that are naturally found in gut and soil environments (Escherichia coli).  Simulated HGT 
was staged by subcloning Atwbc19 under the control of a strong bacterial promoter, 
transforming bacteria with appropriate plasmids and assessing whether kanamycin 
resistance was conferred compared to nptII.  Resistance to a similar aminoglycoside, 
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geneticin (G418), was also assessed to determine if there was potential for cross-
resistance to occur.     
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2. Literature Review 
2.1 Aminoglycoside antibiotics 
2.1.1 Introduction 
Aminoglycosides are powerful bactericidal antibiotics that function by either 
inhibiting protein synthesis by irreversibly binding to prokaryotic ribosome (Recht et al. 
1999) or by creating gaps in the outer membranes of the bacterial cell causing the leakage 
of intracellular contents and enhanced uptake of the antibiotic (Montie and Patamasucon 
1995).  They are among the most common broad-spectrum antibiotics utilized in 
medicine.  Aminoglycosides are effective against gram-negative, aerobic bacteria, but 
also have the ability to act in conjunction against gram-positive bacteria.  
Aminoglycosides are structurally similar and include a variety of compounds:  
kanamycin, neomycin, gentamicin, streptomycin, amikacin, netilmicin and tobramycinn 
(Mingeot-Leclercq et al. 1999).  Their basic chemical structure includes one of several 
aminated sugars joined to dibasic cyclitol using glycosidic linkages (Mingeot-Leclercq et 
al. 1999).  They are polycationic with a high binding affinity for nucleic acids, such as 
portions of RNA or more specifically prokaryotic rRNA (Mingeot-Leclercq et al. 1999). 
Geneticin (G418) has been shown to directly bind to the 80S ribosomal complex of the 
eukaryote and its mechanism may be different from other aminoglycosides (Bar-Nun et 
al. 1983).    Gentamicin, isolated from Micromonospora, is the most commonly used 
aminoglycoside because of its low cost and reliability; however, amikacin is the most 
effective against resistant bacteria.   Streptomycin, the first aminoglycoside, was isolated 
from Streptomyces griseus. Neomycin, isolated from Streptomyces fradiae, has greater 
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potency against gram-negative bacteria; however, because of its high toxicity, it is not to 
be used systemically.   Clinical uses of aminoglycosides include serious gram-negative 
infections, skin, bone or soft tissue infections, urinary tract infections, septicemia, 
peritonitis, severe pelvic inflammatory disease, endocarditis, Mycobacterium infection, 
neonatal sepsis, ocular infections and Otitis externa (Gonzalez and Spencer 1998).    
 
2.1.2 Prevalence of antibiotic resistance in nature 
Antibiotic resistance is relatively common in natural microbial habitats—soil, 
water and gut. Resistance to ampicillin, penicillin and kanamycin occurs naturally in 
many soil bacteria.  Humans consume ca. 1.2 million kanamycin-resistant bacteria each 
day, primarily from fresh vegetables, and resistant bacteria are already present in 10-20% 
of human digestive systems (Calgene 1990).  Each human gut naturally contains 1012 
kanamycin-resistant bacteria, and consumption of the kanamycin-resistance gene would 
merely increase the frequency of kanamycin- resistant bacteria in the gut by 0.000001% 
(Calgene 1990). 
Many of the antibiotics in use have been derived and produced from naturally 
occurring microorganisms (i.e. streptomycin from Streptomyces; Davies and Wright 
1997).  These microorganisms, in turn, have a natural resistance to the antibiotic which 
they produce.  Furthermore, bacteria that produce antibiotics themselves contain 
antibiotic resistance genes as a means of self-protection.  This production of antibiotics is 
believed to be a means of defense against competing bacteria and is a key mechanism of 
survival in nature.   
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Since their increased use in the 1960s and 1970s, the appearance of bacterial 
resistance to aminoglycoside antibiotics has become more prevalent in hospitals and 
patient-associated environments (Davies and Wright 1997).      
 
2.1.3 Aminoglycosidic antibiotics and their uses 
Antibiotics are used as antibacterial compounds, internally and externally, to treat 
and prevent bacterial infections in both humans and animals.  Further, some antibiotics 
are used in livestock farming animals as antibiotic growth promoters to enhance their 
growth and feed efficiency and in plants to help maintain their health.  Antibiotic growth 
promoters are used most widely in swine and poultry. Antibiotics have been used in food 
animal production for more than 50 years to treat, prevent, or control infectious diseases 
or to improve feed efficiencies and weight gain (IFT 2006).  The estimated total annual 
production of antibiotics between the 1970s and 1990s ranged from 31 million to 50 
million pounds, while 18.4 million to 30 million pounds were used in production 
agriculture (IFT 2006).  The amount of antibiotics used by humans in the United States is 
unknown (IFT 2006), and the distribution of antibiotics among humans, veterinary and 
plant applications as well as any estimates for the portion introduced annually into the 
environment are difficult to estimate (IFT 2006).  Fruit trees account for the majority of 
antibiotic use on U.S. plants, with the antibiotics mainly applied to the tree and its 
blossoms, not the fruit (IFT 2006).  The antibiotics most commonly used on plants are 
streptomycin and oxytetracycline.  In the United States, antibiotics applied to plants 
accounts for less than 0.5% of total antibiotic use (Levy 1998).   
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Kanamycin, streptomycin, gentamicin, spectinomycin, butirosin, tobramycin, 
neomycin, amikacin, netilmicin, and isepamicin are aminoglycosides, or biologically 
active secondary metabolites, derived from Streptomyces kanamyceticus, Streptomyces 
griseus, Micromonospora purpurea, Streptomyces spectabilis, Bacillus circulans, 
Streptomyces tenebrarius, Streptomyces fradiae, semisynthetic derivative of kanamycin, 
semisynthetic derivative of sisomicin, and semisynthetic derivative of gentamicin B, 
respectively (Davies and Wright 1997).  These compounds are used as antibiotics to treat 
various diseases including but not limited to tuberculosis, septicemia, complicated 
intraabdominal infections, complicated urinary tract infections, and serious nosocomial 
respiratory tract infections (Gonzalez and Spencer 1998).   
Kanamycin, produced from Streptomyces kanamyceticus, is active against most 
gram-negative bacteria, except Pseudomonas species, and strains of Staphylococcus and 
Mycobacterium.  However, many kanamycin resistant bacteria are widely distributed.  A 
decline in the use of kanamycin has caused a decrease in the prevalence of kanamycin 
resistant bacteria (Opinion of the Scientific Panel on Genetically Modified Organisms 
2004).   
Neomycin, produced from Streptomyces fradiae, is active against many gram-
negative bacteria, except Pseudomonas species, and strains of Staphylococcus aureus.  
Neomycin has chemical properties similar to kanamycin.  Neomycin is used primarily for 
the external treatment of skin, eye and ear infections.  It is poorly absorbed through the 
mouth; however, has been given orally to decrease gut microbes.  Neomycin is both 
ototoxic and nephrotoxic.  Neomycin has limited use clinically and is primarily used in 
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veterinary medicine (Opinion of the Scientific Panel on Genetically Modified Organisms 
2004).      
Streptomycin, produced by Streptomyces griseus, is active against Mycobacterium 
tuberculosis and many other gram-negative bacteria, except Pseudomonas aeruginosa.  
Therefore, it is used in the treatment of tuberculosis and other severe bacterial infections, 
including gonorrhea.  Streptomycin, like neomycin, is poorly absorbed through the mouth 
and is ototoxic.  Streptomycin is also utilized in the treatment of plants and in veterinary 
medicine (Vidaver 2002; Opinion of the Scientific Panel on Genetically Modified 
Organisms 2004; Jana and Deb 2006).   
Paromomycin is similar to neomycin and is used orally in the treatment of 
protozoal infections.  Gentamicin and tobramycin are used in the treatment of life-
threatening gram-negative bacterial infections and oftentimes are used in conjunction 
with other antibiotics such as beta-lactams.  Amikacin and netilimicin are primarily used 
in infections with bacteria that are resistant to other aminoglycosides and neither is 
affected by aminoglycoside modifying enzymes (Jana and Deb 2006).   
 
2.1.4 Resistance mechanisms 
Antibiotics have the potential for selecting for the growth and spread of resistant 
bacteria.     There are three mechanisms of aminoglycosidic resistance:  alteration at the 
target ribosomal binding site, impaired uptake and decreased cell permeability, and 
enzymatic modification (Mingeot-Leclercq et al. 1999).  Mutations occurring at the site 
where the aminoglycoside attaches may impede ribosomal binding.  This mechanism of 
resistance is most common with the antibiotic, streptomycin since it binds to a single site 
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on the 30S subunit of the ribosome.  Other aminoglycosides bind to multiple sites on both 
ribosomal subunits, making their resistance by this mechanism uncommon.  
Aminoglycoside resistance is also observed due to transport defects or inability of the 
aminoglycoside to permeate the membrane, most likely mediated by the chromosome 
(Mingeot-Leclercq et al. 1999).   
The most common mode of aminoglycosidic inactivation and one which results in 
the highest level of resistance is enzymatic modification.  Aminoglycosidic antibiotics 
can be inactivated through the three types of aminoglycoside-modifying enzymes: 
phosphotransferases, nucleotidyltransferases or acetyltransferases.  This reaction requires 
ATP or acetyl CoA and divalent cations as cofactors (Davies and Smith 1978).  O-
Phosphotransferases (APH) catalyzes the ATP-dependent phosphorylation of a hydroxyl 
group, O-Adenyltransferases (ANT) catalyzes the ATP-dependent adenylation of a 
hydroxyl group, and N-Acetyltransferases (AAC) catalyzes acetyl CoA-dependent 
acetylation of an amino group (Davies and Wright 1997).         
 
2.1.5 Importance in human health 
Aminoglycosides are important antibiotics which are bactericidal against aerobic 
gram-negative bacilli as well as active against staphylococci and mycobacterium even 
when inoculum is large.  Common uses of aminoglycosides include treatment for serious, 
life-threatening infections with gram-negative bacteria, infections of the skin, bone or 
soft tissue, urinary tract infections, septicemia, peritonitis or other severe abdominal 
infections, pelvic inflammatory disease, endocarditis, mycobacterium infection, neonatal 
sepsis, ocular infection and otitis externa (Gonzalez and Spencer 1998).   
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The development of antibiotic resistant bacteria of human health importance is of 
greatest concern.  Resistant pathogenic bacteria were first discovered soon after the 
introduction of antibiotics in the 1940s.  Resistance is dependent upon presence of 
antibiotic and resistance gene, and the spread of either the resistant bacteria or resistance 
gene.     
 
2.2 ABC transporters 
2.2.1 Introduction  
ATP-binding cassette (ABC) transporters are membrane proteins that function to 
shuttle nutrient and toxic molecules across the cell’s plasma membrane in order to 
maintain the chemical composition of the cytoplasm.  ABC transporters utilize ATP 
hydrolysis as energy to move both large and small substrates across the membrane.  
Several ABC transporters in plants have been functionally characterized by both their 
involvement in detoxification and in plant development; however, many ABC 
transporters still remain uncharacterized with regards to substrates and functions.   
The ATP-binding cassette (ABC) protein superfamily is the largest known protein 
family with members found in bacteria, fungi, plants and animals (79 members in 
Escherichia coli, 29 members in Saccharomyces cerevisiae, 131 in Arabidopsis 
thaliana), and is mostly composed of membrane proteins actively involved in the 
transport of a variety of substances across phospholipid membranes (Higgins 1992; 
Henikoff et al. 1997).  ABC proteins share 30-40% identity among family members with 
the majority of members being membrane bound with transmembrane domains (TMDs) 
(Higgins 1992).  TMDs appear to form the pathway for movement of solutes, including 
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lipids, heavy metal ions, inorganic acids, glutathione conjugates, sugars, amino acids, 
peptides, secondary metabolites and xenomolecules, across the phospholipid membrane 
and may contribute to the substrate selectivity of the transporter (Higgins 1992; Rea et al. 
1998).       
 
2.2.2 White-Brown Complex subfamily  
The White-Brown complex (WBC) subfamily is the largest subfamily of the 
Arabidopsis ABC protein superfamily and is composed of 29 members (Sanchez-
Fernandez et al. 2001).  The size of WBC subfamilies sequenced in other species is quite 
different.  To contrast, the yeast genome contains only one WBC homolog—ADP1—of 
unknown function while the human genome contains only three—ABC5, ABC8, and 
BCRP1—which are involved in either cholesterol and phospholipids transport or 
multidrug resistance (Decottignies and Goffeau 1997; Berge et al. 2000; Doyle et al. 
1998).   
The WBC subfamily has been identified by homology with the White, Scarlet and 
Brown ABC transporters from Drosophila (Sanchez-Fernandez et al. 2001).  In 
Drosophila, these transporters mediate the transport of pigment precursors into pigment 
cells for eye color (Sanchez-Fernandez et al. 2001).   
 
2.2.3 Discovery and functional characterization of Arabidopsis thaliana WBC 
transporters 
   There have been two genes within the WBC subfamily have been functionally 
characterized—Atwbc19 (At3g21090), the gene that encodes an Arabidopsis thaliana 
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ABC transporter, was found to confer kanamycin resistance to transgenic plants 
(Mentewab and Stewart 2005) and Atwbc12 (At1g51500) was found to play a role in the 
secretion of cuticular wax (Pighin et al. 2004).   
Mentewab and Stewart (2005) while investigating responses of Arabidopsis 
thaliana to explosive 2,4,6-trinitrotoluene (TNT), discovered an endogenous transporter 
gene that conferred resistance to the aminoglycoside antibiotic kanamycin.  Using 
microarray analysis, Mentewab and Stewart (2005) identified 52 genes that were 
upregulated in A. thaliana grown on TNT.  This Atwbc19 gene was further studied 
because its product is a member of the ABC protein superfamily with the ability to 
eliminate and sequester toxins.  While characterizing T-DNA insertion mutants, the root 
growth of Atwbc19 T-DNA insertion mutants on plates containing kanamycin was 
reduced as compared to T-DNA mutants with insertions in other genes.  Mentewab and 
Stewart (2005) demonstrated that Atwbc19 was capable of contributing to kanamycin 
resistance.  When expressed in tobacco, wild-type Atwbc19 confers kanamycin resistance 
at levels comparable to other bacterial antibiotic resistance markers, nptII.       
Pighin et al. (2004) demonstrated that plant ABC transporters were not limited to 
detoxification, but at least one is required for plant cuticular lipid export.  A waxy cuticle 
surrounds and protects all primary aerial tissues of the plant, and the synthesis of this 
waxy cuticle requires the transport of lipids out of the epidermal cells to the plant surface.  
Pighin et al. (2004) identified mutants defective in lipid transport to the cuticle (identified 
as cer mutants).  The phenotype of these mutants includes a glossy, bright green stem due 
to a reduction or alteration in cuticular wax (Koornneef et al. 1989) with cells entirely 
filled with a central vacuole and a thin layer of cytoplasm around the cell’s edge and 
 15
large protrusions of cytoplasm into the vacuole found within the epidermis (Pighin et al. 
2004).  Stem epidermal cells of cer5 mutants contained reduced wax loads and contained 
sheet-like inclusions in the cytoplasm of wax-secreting cells (Pighin et al. 2004).  These 
inclusions were abnormal deposits of cuticular wax and were similar in structure to a 
human disorder caused by a defective peroxisomal ABC transporter.  Pighin et al. (2004) 
isolated the CER5 gene, localized in the plasma membrane, and determined that its 
responsible for encoding an ABC transporter and has been designated WBC12.   
 
2.3 Horizontal gene transfer 
2.3.1 Introduction 
The increased application and usage of biotechnology in the improvement of 
crops has lead to an increase in field trials with genetically modified crops.  A problem 
with this modern approach to plant breeding is the lack of assurance in its safety on both 
the environment and consumers.  One such concern is the potential development of 
antibiotic resistance bacteria from the transfer of antibiotic resistance genes from 
transgenic plants via horizontal gene transfer (HGT).  HGT is defined as the movement 
of genetic material, DNA, to another cell that is not its offspring.  HGT is common 
among prokaryotes, even those not closely related, making it an essential tool in 
evolution and in maintaining diversity of species in the environment.  To contrast, 
vertical gene transfer is where DNA is transferred from a parent to an offspring while 
HGT is the exchange of DNA between cells within the same generation.   
There are three common mechanisms of HGT:  transformation, conjugation and 
transduction.  Of these, transformation is of most interest since it is the only know 
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method by which plant DNA can become incorporated into bacterial DNA.  Natural 
transformation is defined as a process by which competent bacteria can uptake free DNA 
(Stuart and Carlson 1986).  This DNA can then either be incorporated and stably 
maintained in the bacterial genome through homologous recombination or can form an 
autonomous replicating element (Smalla et al. 2000).  There are greater than 70 naturally 
transformable prokaryotic species including many found in the soil as well as some of 
medical importance (de Vries and Wackernagel 2004).  Recombination frequency in 
natural populations is dependent upon natural selection and recombination rate.  If 
transformants are at a disadvantage, they will likely be lost or removed from the 
population.  Transformants that are neutral may either be lost from the population or 
occur at a frequency lower than those that are advantageous.  Thus, genes that provide no 
meaningful function to the bacteria are likely lost from its genome (Ochman et al. 2000).  
Various methods of detecting HGT from plants to bacteria in both the environment and 
under laboratory conditions have been studied and have been found to have certain 
limitations.       
 
2.3.2 Mechanisms of HGT 
Bacteria replicate by cell division and can only obtain new DNA through HGT 
from other cells.  Bacteria utilize conjugation, transduction and transformation to transfer 
and obtain new DNA.   Conjugation requires cell-to-cell contact for the exchange of 
DNA between donor and recipient cells, both of which have to be living and 
metabolically active.  Both gram-positive and gram-negative bacteria can transfer DNA 
via conjugation.  Conjugation can occur between related, distantly related, or unrelated 
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species such as between gram-positive and gram-negative bacteria, from bacteria to 
yeast, and from bacteria to plants (Droge et al. 1998).  Elements involved in conjugation 
transfer and replicate within a broad host range, making conjugation an important method 
for gene transfer among bacteria.  Transduction is the transfer of DNA from bacteria to 
bacteria by bacteriophages.  Bacteriophages attach to bacteria, inject their DNA, and 
produce multiple copies of the bacteriophage which are ultimately released to infect other 
cells.  Bacteriophages have the ability to transfer whole plasmids and pieces of 
chromosomes between hosts.  Many bacteriophages have a narrow host range, only 
infecting one species of bacteria which is usually native to the habitat of the 
bacteriophage (Nielsen et al. 1998).   
Of the bacterial mechanisms to transfer DNA, transformation is the only known 
method by which bacteria can uptake DNA from plants, and therefore is of most concern 
for gene transfer from transgenic plants to bacteria (Thomson 2001).  Transformation is 
defined as the uptake and incorporation of free DNA by and into competent bacteria.  
Transformation requires that the free DNA remains stable and that the bacteria are 
competent.  Currently, there are greater than 70 known bacterial species capable of 
developing competence for transformation (de Vries and Wackernagel 2004).  Natural 
competence has been observed in several bacterial genera, Acinetobacter, Haemophilus, 
Pneumococcus, Streptococcus, Bacillus, Pseudomonas, and Neisseria.  Unlike 
conjugation, transformation does not require that the donor cell be living since oftentimes 
during cell death, lysis occurs and provides free DNA.  Therefore, transformation can 
occur with DNA from any source.     
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2.3.3 Barriers to HGT 
There are certain ecological requirements necessary for the transfer of genetic 
materials from plants to bacteria.  The main barriers for exchange between plants and 
bacteria relate to transfer and establishment (Heinemann 1991).  That is, the bacteria 
must be able to uptake plant DNA and it must have a means to stably maintain it within 
its genome.  Therefore, availability of DNA is the first requirement of HGT.  There are 
four possible fates of free DNA in soil:  degradation, inactivation, stabilization or 
amplification.  Degradation can occur when DNA is fragmented chemically by enzymes 
or mechanically by shearing.  DNA can also be inactivated by binding to substances in 
the soil such as humic acids or clay particles (Stotzky 1989; Tebbe and Vahjen 1993).  
Furthermore, DNA can bind to clay particles within the soil stabilizing it and allowing it 
to maintain or enhance its ability to be transformed (Paget et al. 1992; Stewart et al. 1991; 
Khanna and Stotzky 1992; Gallori et al. 1994; Pietramellara et al. 1997).  Finally, DNA 
can undergo amplification by being taken up, integrated and replicated by transformable 
bacteria.  DNA has been shown to persist in the soil for long periods of time (Lorenz and 
Wackernagel 1987; Ogram et al. 1988; Ogram et al. 1994; Romanowski et al. 1991; 
Romanowski et al. 1993; Paget et al. 1992; Recorbet et al. 1993; Smalla et al. 1994; 
Widmer et al. 1996; Widmer et al. 1997; Gebhard and Smalla 1999).     
In order for natural transformation to occur, free DNA must be accessible at the 
time and place in which competent bacteria inhabit.   Thus, the second requirement and 
potential barrier of HGT is the presence/absence of competent bacteria.  The bacteria 
must be competent to uptake free DNA found in the environment.  That is, the bacteria 
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must have the ability to accept foreign DNA into there genome.   There are currently 
greater than 70 known bacterial species capable of developing competence for 
transformation (de Vries and Wackernagel 2004).     
Further, the DNA must be stably maintained within the bacteria.  This 
stabilization requires the integration of DNA into the bacterial chromosome or for plant 
DNA to contain replication functions with a bacterial origin of replication (Andre et al. 
1986; Koncz et al. 1990).  Integration of DNA into the bacterial chromosome is 
dependent on sequence homology between the free DNA and recipient bacteria (Baron et 
al. 1968; Kondorosi et al. 1980; Rayssiguier et al. 1989; Matic et al. 1995; Matic et al. 
1997; Vulic et al. 1997).  In E. coli it has been determined that the minimal length of 
DNA homology required for homologous recombination is 20 bp (Shen and Huang 
1986).  Stabilization of DNA in bacteria can also occur if the plant DNA contains 
replication function and a bacterial origin of replication (Andre et al. 1986; Koncz et al. 
1990).  If the DNA is fragmented, plasmid rescue-mechanisms may help re-circulate the 
fragmented DNA (Andre et al. 1986; Koncz et al. 1990).     
Finally, another barrier to HGT is the failure to express the genes taken up and 
stabilized within the bacteria.  Although most promoters inserted into transgenic plants 
demonstrate low activity in bacteria, some promoters may also be active in bacteria (e.g. 
35S promoter expresses in E. coli; Assad and Signer 1990).  Stronger antibiotic resistance 
in bacteria may occur if a deletion is restored in the resistance gene or if its expression is 
upregulated following recombination.    
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2.3.4 HGT detection and its limitations 
Many studies have monitored the likelihood of and potential risks associated with 
HGT between/among bacteria (Eisen 2000; Beiko et al. 2005; Gogarten and Townsend 
2005; Thomas and Nielsen 2005), from transgenic plants to soil microbes (Badosa et al. 
2004; Broer et al. 1996; de Vries and Wackernagel 1998; de Vries and Wackernagel 
2001; de Vries and Wackernagel 2004; Gebhard and Smalla 1998; Gebhard and Smalla 
1999; Kay et al. 2002; Kowalchuk et al. 2003; Nielsen et al. 1997; Nielsen et al. 2000; 
Schluter et al. 1995; Shin et al. 2004; Smalla et al. 2000; Tepfer et al. 2003), from 
transgenic plants to gut microflora (Chambers et al. 2002; Deni et al. 2005; Duggan et al. 
2000) in the environment as well as under laboratory conditions.  There have been 
several methods utilized for the detection of HGT from plants to bacteria:  comparison of 
DNA sequences, screening of bacteria from environmental samples, and experimental 
studies of HGT from transgenic plants to bacteria under optimized laboratory conditions 
(Nielsen et al. 1998).     
One approach utilized in detecting HGT from plants to bacteria is through the 
comparison of DNA sequences.  This method evaluates similarities between bacterial and 
plant DNA in nucleotide sequences, G+C content, codon usage and protein sequence and 
structure and is viewed as controversial (Smith et al. 1992; Shatters and Kahn 1989).  
Several incidences of HGT from plants to bacteria have been reported using this method 
of detection.  Genes that were examined for HGT include:  glutamine synthetase II from a 
eukaryote to Bradyrhizobium japonicum (Carlson and Chelm 1986), glyceraldehydes 3-
phosphate dehydrogenase from a eukaryote to E. coli (Doolittle et al. 1990), glucose 6-
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phosphate isomerase from Clarkia urgulata to E. coli (Froman et al. 1989), and 
leghemoglobin gene to Vitreoscilla (Lamour et al. 1994).  Problems with this method of 
detection include the need for known DNA sequences evaluated in both related and 
unrelated organisms (Smith et al. 1992) and the interpretations must be inferred.      
A second approach in detecting HGT from plants to bacteria is through the 
surveying of bacteria from environmental samples (soil or plants).  The persistence of 
transgenic plant DNA in the soil has been demonstrated in several studies (Gebhard and 
Smalla 1999; Glick 1995; Widmer et al. 1996).  A study on the persistence of DNA from 
transgenic sugar beet in soil and the horizontal transfer of its DNA to bacteria 
demonstrated persistence of its DNA was detectable for up to 2 years following its 
release under field conditions; however, there was no evidence of HGT to soil bacteria 
(Gebhard and Smalla 1999; Glick 1995).  From laboratory experiments, transgenic plant 
DNA was detectable by PCR for greater than 130 days (Widmer et al. 1996).  Therefore, 
the soil can be a potential source of transgenic plant DNA months to years after 
transgenic crops are no longer present.  The sensitivity of detection for this method is low 
due to the differences in cultivation requirements for soil bacteria, the selection agent, 
plating efficiency, and background interference.   
The final approach used in detecting HGT from plants to bacteria is through 
experimental studies.  HGT studies have been conducted under the assumption that gene 
transfer occurs by natural transformation and have been done in laboratory using gram-
negative soil or plant bacteria (Agrobacterium, Erwinia, and Acinetobacter).  The 
horizontal transfer of genes from bacteria to plants is most well known in the transfer of 
DNA from Agrobacterium tumefaciens to plant genomes (Zupan et al. 1998; Smith et al. 
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2001).  Broer et al. (1996) examined the ability of A. tumefaciens to receive T-DNA 
integrated by transgenic tobacco.  Homologous recombination between this DNA region 
and the corresponding region on the Ti plasmid of A. tumefaciens was expected to occur.  
However, transformants could not be detected (Broer et al. 1996).  Transformation 
frequencies were determined to be below detection limits of 6 × 10-12.  HGT has been 
examined using DNA from transgenic potato and transgenic sugarbeet, both containing 
the nptII gene, to the bacteria Acinetobacter calcoaceticus (Nielsen et al. 1997).  
Transformation conditions were optimized with chromosomal DNA and a transformation 
frequency of 10-2 was determined in vitro (Nielsen et al.1997).   
Detection transformation frequencies vary widely among studies (Schluter et al. 
1995; Broer et al. 1996; Nielsen et al. 1997; Gebhard and Smalla 1998; de Vries and 
Wackernagel 1998) and are estimated at low frequencies, 2 × 10-17 (Schluter et al. 1995), 
6 × 10-12 (Broer et al. 1996), 10-2 (Nielsen et al. 1997), 5.4 ×10-9 (Gebhard and Smalla 
1998) and 3.5 × 10-8 (de Vries and Wackernagel 1998).  With such low detection 
frequencies, questions still remain whether HGT, from transgenic plants to bacteria, may 
impact the environment.   
Heinemann and Traavik (2004) examined the problems associated with 
monitoring HGT from transgenic plants to soil bacteria in the environment and found that 
methods of environmental sampling are probably too insensitive for HGT monitoring and 
suggested that the sensitivity of current detection techniques for its monitoring HGT may 
be a trillion times lower than frequency estimates currently found in the literature.  
Recent publications raise concerns that HGT between plants and soil microorganisms 
may be underestimated.  However, it has been argued that the likelihood of a gene 
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transfer event from a transgenic plant to a bacterium is rare (Schluter et al. 1995; Broer et 
al. 1996; Nielsen et al. 1997; Gebhard and Smalla 1998; de Vries and Wackernagel 
1998).       
   
2.4 Markers used in plant biotechnology 
2.4.1 Introduction 
There are many selectable marker genes utilized and expressed in transgenic 
plants across the United States (Malik and Saroha 1999; Miki and McHugh 2004) (Table 
1).  The majority of markers used in plant biotechnology are antibiotic resistance markers 
(ARMs) and were first used either in preparing plant transformation vectors or used 
within the plant transformation process itself (Goldstein et al. 2005).  Although selectable 
marker genes derived from bacteria have been recognized as safe by regulatory agencies, 
concerns have been raised on their potential risks to human health.  Controversy remains 
on the potential for human pathogens to develop resistance to antibiotics used in human 
and animal health.  There is evidence that drug resistance is already widespread in 
bacteria as a consequence of overuse in human and veterinary medicine and as animal 
growth promoters (IFT 2006).       
However, there are alternatives to using bacterial derived antibiotic resistance 
markers in transgenic research, such as the production of marker-free plants, which can 
be more difficult and less efficient (Miki and McHugh 2004), the use of reporter genes as 
visible markers (Miki and McHugh 2004), the use of markers that confer resistance to 
chemicals other than antibiotics, such as herbicides, (Miki and McHugh 2004), or the use 
of selectable markers derived from plants (Mentewab and Stewart 2005).    
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Alternatives include, but are not limited to, the pat and bar genes encoding 
phosphinothricin acetyltransferase which detoxify L-phosphinothricin; 5-enolpyruvyl-
shikimate-3-phosphate synthase (EPSPS) conferring resistance to glyphosate; 
acetolactate synthase (ALS) conferring resistance to chlorosulfuron; bromoxinil nitrilase 
(Bxn) conferring resistance to bromoxinil; and the recently discovered Atwbc19 gene 
conferring resistance to kanamycin. 
There are numerous safety concerns relating to the use of antibiotic resistance 
markers in biotechnology, more specifically in the creation of transgenic plants.  ARMs 
that confer resistance to antibiotics of clinical significance, particularly those to which 
resistance is not widely spread in the environment, should be avoided.  The US 
FDA/CFSAN has published guidance for industry on the use of antibiotic resistance 
markers in transgenic plants (US FDA/CFSAN 1998). 
   
2.4.2 Antibiotic resistance markers 
The main markers used in plant biotechnology confer resistance to some 
antibiotic.  The US FDA/CFSAN (1998) has provided a document on the guidance for 
industry on the use of antibiotic resistance marker genes in transgenic plants.  The most 
popular antibiotic resistance markers include neomycin phosphotransferase (nptII) 
conferring kanamycin resistance, aad-3 conferring resistance to streptomycin and 
spectinomycin, and hph conferring resistance to hygromycin.  These antibiotics are toxic 
to many plant species, especially dicotyledons. 
The neomycin phosphotransferase (nptII) gene encodes aminoglycoside 3’-
phosphotransferase II and was first isolated as a component of transposon Tn5 from 
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Escherichia coli (Garfinkel et al. 1981; Miki and McHugh 2004).  The nptII gene confers 
resistance to the antibiotics neomycin and kanamycin, and it is a popular selectable 
marker in plant biotechnology.  Neomycin and kanamycin are not of importance in 
human/animal medical treatment, and on average, 20 to 40% of naturally occurring gut 
bacteria are already resistant to kanamycin (Braun 2001).  Further, kanamycin resistant 
bacteria are ubiquitous in nature.  Humans consume 1.2 million kanamycin-resistant 
bacteria each day, primarily from fresh vegetables, and resistant bacteria are already 
present in 10-20% of human digestive systems (Calgene 1990).  Each human gut 
naturally contains 1012 kanamycin-resistant bacteria.   
The aad-3 gene confers resistance to both streptomycin and spectinomycin 
(Gilman et al. 1996).  Streptomycin was used commonly in the 1950s and 1960s; 
however, due to a high frequency in bacterial resistance and large occurrences of 
ototoxicity, it no longer is highly used in the treatment of tuberculosis (Gilman et al. 
1996).  Spectinomycin is an aminoglycoside-like antibiotic used in the treatment of joint 
infections caused by gonorrhea (WHO 1991).  
The hph gene, derived from a fungus, confers resistance to hygromycin which is 
an aminoglycoside analogue, and is used in the selection of transgenic plants and 
organisms (Day 2003; Miki and McHugh 2004).  Hygromycin is not used significantly in 
human or veterinary medicine and has not conferred resistance to other clinically relevant 
aminoglycosides (Wright and Thompson 1999).   
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2.4.3 Alternative markers to antibiotic resistance genes 
There are several alternatives to using bacterial derived antibiotic resistance 
markers in transgenic research, such as the use of chemical markers, production of 
marker-free plants, which can be more difficult and less efficient (Miki and McHugh 
2004), the use of reporter genes as visible markers (Miki and McHugh 2004), or the use 
of selectable markers derived from plants (Mentewab and Stewart 2005).   
Some markers confer resistance to chemicals other than antibiotics, such as 
herbicides or lethal concentrations of the amino acids, lysine and threonine, while others 
rely on the growth of plant cells in the presence of atypical nutrients, such as cytokinin, 
glucuronides, xylose or mannose (reviewed by Miki and McHugh 2004).  Herbicide-
resistance selectable markers include, but are not limited to, phosphinothricin 
acetyltransferase (pat and bar genes), 5-enolpyruvyl-shikimate-3-phosphate synthase 
(EPSPS), (resistance to glyphosate), acetolactate synthase (ALS) (resistance to 
chlorosulfuron), and bromoxinil nitrilase (bxn) (resistance to bromoxinil).  
Two genes, pat and bar, encode the enzyme, phosphinothricin acetyltransferase, 
which confers tolerance to PPT in transgenic plants.  PPT is an inhibitor of glutamine 
synthetase, which catalyzes ammonia into glutamic acid in plants.  Inhibition of this 
enzyme results in the accumulation of toxic levels of ammonia within the plant, causing 
plant death (OECD 1999).  Glyphosate inhibits EPSPS, an essential enzyme in the 
shikimate pathway for aromatic amino acid biosynthesis.  ALS is the target for several 
herbicides including sulfonylureas, imidazolinones, triazolopyrimidines, and pyrimidinyl 
thiobenzoates (Singh and Shaner 1995).  ALS is a regulatory enzyme in the biosynthetic 
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pathway to branched-chain amino acids in chloroplasts.    Bromoxynil nitrilase 
hydrolyzes bromoxynil into 3,5-dibromo-4-dihydroxybenzoic acid and ammonia.           
Non-selectable marker genes or reporter genes can be used in conjunction with 
selectable marker systems.  Reporter genes can visible detect transformed cells or tissues.  
Popular reporter genes include green fluorescent protein (GFP) (reviewed by Stewart 
2001), luciferase (Ow et al. 1986), β-galactosidase (Helmer et al. 1984), and β-
glucuronidase (GUS) (Jefferson et al. 1987; Kilian et al. 1999; Daniell et al. 1991).    
A final alternative is the use of markers derived from plant sources instead of 
bacterial sources.  The plant gene, Atwbc19, encodes an Arabidopsis thaliana ATP 
binding cassette (ABC) transporter has been shown to confer kanamycin resistance to 
transgenic plants (Mentewab and Stewart 2005).   
 
2.4.4 Implications of ARMs on human and animal health 
There are numerous safety concerns relating to the use of antibiotic resistance 
markers in biotechnology, more specifically in the creation of transgenic plants; the 
safety of the gene and the gene product and the potential for the gene to be transferred to 
bacteria and create a risk to human health (Gay and Gillespie 2005).  The latter has been 
discussed in detail in section 2.3 Horizontal Gene Transfer.   
Antibiotic resistance occurs when an antibiotic is no longer effective in killing or 
inhibiting bacterial growth.  The major cause of resistance is believed to be the overuse or 
inappropriate use of antibiotics in human and animal health (Braun 2001).  Gene flow 
among bacteria is a well-established process of microbial evolution, as observed in the 
development of multi-drug resistant bacteria (Tschape 1994; Salyers and Shoemaker 
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1994; Witte 1998).  The implications of ARMs on human and animal health are related 
more to the persistence of transgenic plant DNA in the environment from processing, 
ingestion and digesting (Braun 2001).  Further, most ARMs utilized in the production of 
transgenic plants do not use antibiotics that are used clinically in human and animal 
health (Braun 2001).  Thus, the likelihood of developing resistance is of little concern in 
human and animal health (Braun 2001).   
However, of more concern in human and animal health, is the potential for cross-
resistance.  Antibiotic cross-resistance is the tolerance to other antibiotics when exposed 
to a similar substance (Mikkelsen et al. 1999).  That is, the development of G418 
resistance when exposed to kanamycin resistance.  Cross-resistance is of concern with 
aminoglycosidic antibiotics since many of the aminoglycosides are similar in structure.  
In general, for human and animal health, ARMs that confer resistance to antibiotics of 
clinical significance, particularly those to which resistance is not widely spread in the 
environment, should be avoided. 
 
2.4.5 Regulations regarding the use of ARMs in transgenic plants 
The US FDA/CFSAN has published guidance for industry on the use of antibiotic 
resistance markers in transgenic plants (US FDA/CFSAN 1998. There are five topics 
discussed relating to the transfer of antibiotic marker genes :  direct effects of the 
ingestion of enzyme encoded by antibiotic resistance marker genes, potential transfer of 
antibiotic marker genes to gut epithelial cells, gut microorganisms and microorganisms in 
the environment and approaches to and surveillance for the potential transfer of antibiotic 
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resistance marker genes and their resistance.  These topics have been covered in detail in 
previous sections.   
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3. Objectives 
The objective of this study was to determine the ability of bacteria to confer 
aminoglycoside resistance to a newly discovered plant ABC transporter that confers 
kanamycin resistance when overexpressed in transgenic plants.  This study examined the 
ability of Escherichia coli to confer kanamycin, gentamicin and geneticin resistance 
when transformed with either nptII or Atwbc19.  
Simulated HGT was staged by subcloning Atwbc19 under the control of a strong 
bacterial promoter, transforming bacteria with appropriate plasmids and assessing 
whether kanamycin resistance was conferred compared to nptII.  Resistance to a similar 
aminoglycosides, geneticin (G418) and gentamycin, were also assessed to determine if 
there was potential for cross-resistance to occur.     
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4. Materials and Methods 
4.1 Bacterial strains and plasmids 
Escherichia coli DH5α was used in all experiments and cultured on Luria-Bertani 
(LB) media (Luria and Burrous 1955; Luria et al. 1960; Miller 1972).  Three plasmids 
were used in this study.  Plasmids were obtained from Mentewab Ayalew, a former 
postdoctoral associate at the University of Tennessee.  In all cases HGT is mimicked by 
the subcloning of the gene that would be in T-DNA under the control of a plant promoter 
so that it is now under the control of a strong inducible bacterial promoter; modeling a 
worst-case HGT scenario.   pKS-ABC contains the Atwbc19 gene under the control of the 
lacZ promoter in pBluescript II SK+; pKS-nptII contains the nptII gene with the lacZ 
promoter in pBluescript II SK+; and pKS is pBluescript II SK+ with no inserted genes as 
a control (Fig. 1) (all figures and tables located within appendix).  The microorganisms 
were maintained in glycerol stocks and stored at -80°C.  Working cultures were obtained 
by inoculating a loopful of culture into 50 ml LB broth supplemented with ampicillin 
(100mg L-1) and incubated at 37°C for 24 hr. Inserts were sequenced at 5’ and 3’ ends as 
confirmation. 
 
4.2 Determining susceptibility of Escherichia coli to kanamycin 
 E. coli DH5α without any of the experimental plasmids was examined for 
resistance to varying levels of kanamycin prior to transformation experiments.  Briefly, 
bacteria were grown overnight in 50 ml cultures to approximately 1 × 109 CFU ml-1, 
serially diluted and placed in LB with kanamycin (0, 25, 50 and 100 mg L-1).  Tubes were 
incubated overnight at 37°C and turbidity observed after 24 hr incubation.  Only those 
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strains that were susceptible (i.e. no visible turbidity) at the lowest level (25 mg L-1) of 
kanamycin were used for the horizontal gene transfer experiments. 
 
4.3 Determining potential usage of other bacteria in HGT studies 
Other soilborne bacteria were examined for potential use in these experiments:  
Variovorax sp. UTK 037, Acidovorax sp. UTK 052 and Rahnella sp. UTK 034 were 
examined for their natural resistance to ampicillin and kanamycin (Fig. 2).  Ampicillin 
was utilized since it was the ARM utilized in initial experiments for plasmid selection in 
bacteria.   
 
4.4 Transformation  
E. coli DH5α was transformed with pKS, pKS-ABC, and pKS-nptII by a 
freeze/thaw method (Hanahan 1983).  For selection of transformants, aliquots of bacteria 
were spread onto solidified LB medium supplemented with ampicillin (100 mg L-1) and 
incubated at 37°C for 24 hr. 
 
4.5 Assessment of new antibiotic resistance through natural transformation 
Transformed bacteria were observed for their ability to acquire kanamycin, 
geneticin (G418), and gentamycin resistance using growth assays 96-well microtiter 
plates.  Isopropyl-b-D-thiogalctopyranoside (IPTG) at 1 mM was used to induce the lacZ 
promoter.  Each well was filled with 199 µl LB, IPTG and varying concentrations of 
antibiotic (kanamycin, geneticin (G418), and gentamycin) and 50 µl bacterial treatments.  
Each treatment was replicated in triplicate in sterile 96-well microtiter plates and each 
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experiment was duplicated in time.  Optical densities were measured at 630 nm after 
incubating microtiter plates at 37°C for 24 hr.  
Antibiotics with cationic structures may bind electrostatically to acid or sulfate 
groups in LB media and thus, decrease the effectiveness of the aminoglycoside 
(Amsterdam 1996).  Thus, Mueller-Hinton (Mueller and Hinton 1941) broth was tested 
instead of LB to examine if this was the case in this system.    
 
4.6 Statistical analysis 
Data were analyzed by analysis of variance (ANOVA) using the general linear 
model.  Duncan’s Multiple Range test was used to compare treatment mean values when 
significant differences (at the 0.05 probability level) were found.  All analysis was 
performed using the SAS program (Statistical Analysis Systems 9.1, SAS Institute, Inc., 
Cary, NC).   
 
4.7 Reverse transcription polymerase chain reaction 
 Initial expression studies for the antibiotic resistance genes were performed using 
reverse transcription PCR. RNA was extracted using the RNeasy Mini Kit following the 
manufacturer’s protocol (Qiagen, Valencia, CA, USA).  Two micrograms of template 
was used in the iScript cDNA synthesis reaction following the manufacturer’s 
instructions using half reactions (Bio-Rad, Hercules, CA, USA).  Quality of cDNA 
synthesis was examined using 1% agarose gel electrophoresis.    PCR was performed 
using the following primers:  ABC forward (5’-GAG GCA GGG ACA CAA GAG AG-
3’), ABC reverse (5’-TGT CCC CGT TTT TAT CCA AG-3’), neomycin forward (5’-
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CTT GGG TGG AGA GGC TAT TC-3’), neomycin reverse (5’-AGG TGA GAT GAC 
AGG AGA TC-3’) (Integrated DNA Technologies, Inc., Coralville, IA, USA) and 
following protocol Eppendorf MasterMix.  Expression was observed using a 1% agarose 
gel. 
 
4.8 Northern blot analysis 
Northern gel blot analysis was performed to assess gene expression of Atwbc19 
and nptII under the experimental conditions. Fifteen-hundred microliter samples were 
taken from triplicate wells for each plasmid (pKS, pKS-ABC and pKS-nptII) at 0 and 
either 6.5 or12.5 mg L-1 G418 or kanamycin respectively at 24 h for northern blot 
analysis.  RNA was extracted using the RNeasy Mini Kit and following manufacturer’s 
protocol (Qiagen, Valencia, CA, USA). RNA was examined for quality and quantity by 
1% agarose gel electrophoresis (Fig. 3).  Five micrograms of RNA was loaded in each 
well.  After electrophoretic separation, bacterial RNA was transferred to a nylon 
membrane by capillary action and probed with either Atwbc19, nptII or 16S rRNA 
radiolabelled with [32P-dCTP] using random primers created using Prime-It® II Random 
Primer Labeling Kit (Stratagene, LaJolla, CA, USA) and purified using mini Quick Spin 
Columns (Roche Applied Science, Indianapolis, IN, USA).  Prior to probing, Atwbc19 
and nptII were excised from a 1% gel (Fig. 4), purified using QiaQuick spin columns 
(Qiagen, Valencia, CA, USA), and checked for quality (Fig. 5).  Hybridization was 
performed using ULTRAhyb™ hybridization buffer following the manufacturer’s 
instructions (Ambion, Austin, TX, USA).    
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5. Results  
E. coli DH5α without any of the experimental plasmids was examined for 
resistance to kanamycin.  No growth (i.e. no turbidity) was observed at 25 mg L-1, 50 mg 
L-1 or 100 mg L-1.  Turbidity was only observed at the 0 mg L-1 (no kanamycin) control. 
When testing broth differences, observations indicated a decreased growth overall 
resulting in OD readings reaching only 0.3 after 24 hr when Mueller-Hinton broth was 
used in place of LB (Fig. 6).  Furthermore, it appeared that the minimum inhibitory 
concentrations (MICs) were lower when using the alternative media.  However, growth 
of bacteria in Mueller-Hinton broth containing no antibiotic was decreased as well, 
indicating our bacteria grew better in LB.  However, further tests would need to be 
conducted to fully observe the influence of media type on MIC.   
When soilborne bacteria were tested for their ability to be used in subsequent 
experiments, Acidovorax was slow-growing and could not be compared effectively in 
these experiments (Fig. 2).  Rahnella and Variovorax appeared to demonstrate resistance 
to ampicillin, making it difficult to screen in cloning experiments (Fig. 2).  Rahnella 
appeared less resistant to kanamycin than Variovorax (Fig. 2).  Thus, these bacteria were 
not utilized in any further experiments. 
The nptII gene provided greater resistance to kanamycin in E. coli than that of the 
Atwbc19 gene and was significantly different from the no-plasmid control at higher 
concentrations of kanamycin (e.g., over 10 mg L-1) (p<0.05) (Fig. 7).  The Atwbc19 gene 
was not significantly different from the no-plasmid control at higher concentrations of 
kanamycin (e.g., over 25 mg L-1) (p<0.05).  E. coli transformed with pKS-ABC showed 
little resistance to kanamycin at 100 mg L-1, the level that was most effective in the 
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selection of transgenic tobacco (Mentewab and Stewart 2005; Fig. 7).  NptII, however, 
conferred kanamycin resistance at the 100 mg L-1concentration as well at the 400 mg L-1, 
the highest concentration tested (Fig. 7).  Atwbc19 conferred resistance to only lower 
concentrations of kanamycin to E. coli (below 12.5 mg L-1) that was not significantly 
different from that conferred by nptII.    
 The nptII gene provided greater resistance to G418 in E. coli than that of the 
Atwbc19 gene and was significantly different from the no-plasmid control at 
concentrations over 1 mg L-1 (p<0.05) (Fig. 8).  NptII endowed G418 resistance at the 
100 mg L-1 concentration, the highest tested (Fig. 8).   
 There was no significant difference between the no-plasmid control, pKS-nptII or 
pKS-ABC at gentamicin concentrations greater than 1 mg L-1 (Fig. 9).  Each plasmid 
followed a similar growth pattern with none displaying resistance at any level greater 
than 1 mg L-1 (Fig. 9). Gentamicin, used in human therapeutics, is composed of a mixture 
of antibiotic substances, C1 (25-50%), C1a (10-35%), and gentamicins C2a and C2 (25-
55%) (McAllan and Smith 1973).  Gentamicins A and B are only minor components of 
the commercial drug and APH (3’) II, and thus, does not confer resistance (Davies 1986).  
This minor composition may explain the lack of resistance observed in pKS-nptII (Fig. 
9). 
Gene expression levels were found to be similar between pKS-ABC and pKS-
nptII from RT-PCR analysis (Fig. 10).  Expression levels for nptII were similar to that of 
Atwbc19 for the two concentrations of the antibiotic kanamycin tested (Fig. 11).  Equal 
loading of RNA was observed with methylene blue staining of RNA adhered to the nylon 
membrane (Fig. 11).  There was a slightly apparent decrease in the level of expression for 
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Atwbc19 compared to the nptII gene that was most likely the result to the plant codon 
usage of the ABC gene or its large size (over two-fold greater size than nptII) (Fig. 11).  
All other samples of pKS-nptII were similarly expressed (Fig. 11B).    
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6. Discussion 
Previous research has addressed the potential for horizontal gene transfer to occur 
from transgenic plants to environmental bacteria (Gebhard and Smalla 1998; de Vries and 
Wackernagel 1998).  Gebhard and Smalla (1998) demonstrated the ability of 
Acinetobacter sp. BD413 to utilize and integrate transgenic plant DNA under laboratory 
conditions.  Furthermore, de Vries and Wackernagel (1998) reported the restoration of 
Acinetobacter sp. BD413 cells containing an nptII gene with a 10 bp deletion when 
transformed with DNA from transgenic Solanum tubersosum, Nicotiana tabacum, Beta 
vulgaris, Brassica napus, and Lycopersicon esculentum carrying an nptII marker gene.   
Mentewab and Stewart (2005) recently described a plant gene that confers 
kanamycin resistance to transgenic plants—the ABC transporter Atwbc19.  Transgenic 
plants with the Atwbc19 gene, with and without an nptII cassette confer resistance to 
kanamycin similar to that of nptII in transgenic plants.  Here we have demonstrated that 
when HGT is staged by subcloning Atwbc19 under the control of a strong bacterial 
promoter, it did not confer kanamycin resistance comparable to that of the nptII gene in 
E. coli.  Many researchers have failed to detect HGT from transgenic plants to bacteria, 
most likely due to the absence of homologous sequences in the bacteria (Nielsen et al. 
1997) or the use of bacteria with decreased transformation efficiency (Schluter et al. 
1995; Broer et al. 1996).  Here we utilize E. coli DH5α, a highly transformable bacteria 
and optimize transformation using a strong bacterial promoter and demonstrated the 
inability of the Atwbc19 gene to confer resistance to the aminoglycoside antibiotic 
kanamycin to that of the nptII in the soil bacterium E. coli at high concentrations (e.g., 
over 10 mg L-1).   
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Another explanation for the inability to detect HGT may be due to only 
monitoring the transfer of the complete gene, not merely segments of the DNA (Smalla 
2000).  As with previous laboratory studies with nptII and its transfer to bacteria under 
laboratory conditions, we found that the nptII gene provided resistance to kanamycin in 
bacteria (Gebhard and Smalla 1998).     
Nielsen et al. (1998, 2001), Bertolla and Simonet (1999), Droge et al. (1998) and 
Thomson (2001) have published reviews of the work on horizontal gene transfer from 
transgenic plants to bacteria or mammalian cells.  Many researchers have conducted 
experiments to mimic the movement of DNA from transgenic plants to environmental 
bacteria and fungi under field conditions (Paget et al. 1998; Gebhard and Smalla 1999).  
Experimental attempts to establish HGT of transgenic DNA to bacteria under laboratory 
conditions have been negative.  Furthermore, no experiment, to date, has shown evidence 
of transfer of transgenes or other genes from plants to soil bacteria under non-laboratory 
conditions.   
These findings confirm results of previous HGT field test of transgenic crops.  
There have been no detectable transfer of transgenes to soil bacteria under natural 
conditions (Smalla et al. 1994; Paget and Simonet 1994; Badosa et al. 2004); however, 
HGT from transgenic plants to bacteria under optimized conditions has been 
demonstrated (Hoffman et al. 1994; Schluter et al. 1995; Gebhard and Smalla 1998; de 
Vries and Wackernagel 1998; Nielsen et al. 2000; Meier and Wackernagel 2003).   
Hoffman et al. (1994) used transgenic Brassica plants and the filamentous fungi, 
Aspergillus niger, as a model system and demonstrated successful transformation of A. 
niger with the hygromycin B antibiotic resistance marker gene; however, the transfer 
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frequency was too low to calculate.  Schluter et al. (1995) simulated HGT between 
transgenic potatoes, Solanum tuberosum, and the plant pathogenic bacterium, Erwinia 
chrysanthemum, in an effort to calculate HGT under various conditions and found that 
even under “idealized” natural conditions (using a bacterial marker gene linked to a 
functional origin of replication), a calculated HGT frequency of 2 × 10-17, a rate far below 
detection limits.     
Other studies were conducted utilizing the bacterial-derived antibiotic resistance 
gene (nptII) incubated with natural transformable bacteria with a non-functioning copy of 
nptII (Gebhard and Smalla 1998; De Vries and Wackernagel 1998; Nielson et al. 2000; 
Meier and Wackernagel 2003).  HGT was determined based on the return of antibiotic 
resistance of the non-functioning nptII.  Low transfer frequencies of 3 × 10-8 (de Vries 
and Wackernagel 2003) and 5.4 × 10-9 (Gebhard and Smalla 1998) were detected.  Broer 
et al. (1996) infected Agrobacterium tumefaciens with the T-DNA from transgenic 
tobacco, Nicotiana tabacum, but were unable to detect HGT from plant to bacteria due to 
the inability of the bacterium to develop competence and uptake DNA.  Nielson et al. 
(1997) found no HGT between transgenic plants and Acinetobacter under laboratory 
conditions. 
There is no evidence that Atwbc19 has been transferred to bacteria during 
evolution (Mentewab and Stewart 2005).  Furthermore, there are ABC transporters found 
in prokaryotes; however, database searches have not disclosed bacterial ABC transporter 
orthologues with plant-like codon use patterns (Mentewab and Stewart 2005).  
Previous observations have indicated that Atwbc19 is very specific for kanamycin 
and resistance to no other aminoglycoside antibiotics was displayed (Mentewab and 
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Stewart 2005).  In addition Atwbc19 is 2.75 times larger than nptII and has plant codon 
usage.  E. coli transformed with pKS-ABC showed little resistance to kanamycin at 100 
mg L-1, 10 times less than the level of resistance found in enterococci isolated from 
coastal bathing waters (Arvanitidou et al. 2001).  This lack of resistance demonstrated by 
bacteria transformed with the Atwbc19 gene along with the Atwbc19 gene’s specificity to 
kanamycin, larger size, and its usage of plant codon, demonstrates a decrease in the 
potential threat to transfer its resistance to bacterial pathogens.  At least if it were 
transferred to bacteria it would not confer kanamycin resistance.  Mentewab and Stewart 
(2005) inferred that Atwbc19 was targeted to the tonoplast when overexpressed in plants.  
Since the tonoplast and central vacuole are absent in bacteria, it is likely mis-targeted to 
some degree to the cell membrane (Fig. 12).  In plants there is active transport of 
kanamycin into the vacuole where it is sequestered.  Since bacteria lack a central vacuole 
this mechanism cannot occur for toxin sequestration (Fig. 12).  The decrease of Atwbc19 
in bacteria can be largely be explained by differences of transgene subcellular targeting 
between plants and bacteria. The low level of Atwbc19-conferred kanamycin resistance in 
bacteria is likely caused by an inefficient cell membrane targeting of the overproduced 
protein that attempts to pump kanamycin out of cells. 
The neomycin phosphotransferase II gene was originally isolated as a component 
of the transposon Tn5 from E. coli (Beck et al. 1982) and is an enzyme that catalyzes the 
transfer of acetyl, adenosine monophosphate or phosphate groups onto the 
aminoglycoside antibiotics, including kanamycin, neomycin, paromomycin, 
ribostamycin, gentamicins A and B and butirosins (Wright et al. 1998; FDA/CFSAN 
1998).  This transfer, in turn, contributes to the nptII gene’s greater ability to resist higher 
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kanamycin concentrations in bacteria.  Bacteria have membrane transport systems that 
function to deliver essential nutrients into the cell, maintain homeostasis, export proteins; 
and control efflux of xenobiotic/antibiotic compounds (Paulsen et al. 1998).  Of the 
above mentioned aminoglycosides, kanamycin and neomycin are not currently used 
medically for either animals or humans (FDA/CFSAN 1998).  Geneticin (G418) is an 
aminoglycoside antibiotic similar in structure to gentamicin, neomycin and kanamycin.  
G418 is an analog of neomycin sulfate and interferes with the function of the 80S 
ribosome and protein synthesis in eukaryotic and prokaryotic cells.  And thus, the 
aminoglycoside transferase gene confers resistance. 
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7. Conclusions 
  Antibiotic resistance genes are naturally present in soils, water and bacteria.  
Transgenic research utilizes these markers to select for transformed plant cells.  A series 
of articles has debated the safety of ARMs in transgenic plants, and controversy still 
remains on their impact to environment and human health (Nielsen et al. 1998; Smalla et 
al. 2000; Kowalchuk et al. 2003; Heinemann and Traavik 2004; Gay and Gillespie 2005).  
One concern that researchers wish to resolve is the potential of horizontal transfer of 
resistance genes from transgenic plants to bacteria of medical importance.  Currently, the 
antibiotic resistance genes used in transgenic studies have been bacterial in origin, with 
the exception of the ABC transporter, Atwbc19, the first plant gene shown to confer 
kanamycin resistance in transgenic plants.  The Atwbc19 gene was evaluated for its 
ability to transfer antibiotic resistance to bacteria found in the environment (E. coli 
DH5α).  In this research, it was determined that if the Atwbc19 gene were to be 
transferred to E. coli and it were to land under the control of a strong inducible bacterial 
promoter, that low levels of kanamycin resistance would be conferred as a result.    
Further research needs to be conducted to assess the safety of the Atwbc19 gene as 
an alternative antibiotic resistance marker in the creation of transgenic plants (i.e. 
examine bacteria of medical importance).  This gene is an effective alternative to the 
bacterial nptII gene in transgenic plants. 
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Figure 1.  Constructs utilized in all transformation experiments.  pKS-ABC (A) contains 
the Atwbc19 gene under the control of the lacZ bacterial promoter in pBluescript II SK+; 
pKS-nptII (B) contains the nptII gene with the lacZ bacterial promoter in pBluescript II 
SK+; and pKS (C) is pBluescript II SK+ with no inserted genes as a control. 
Genes were inserted into pKS using KpnI and SacI restriction sites.  Initial transformants 
were selected using ampicillin resistance.   
lac
prom AtWBC19
b-galactosidase
fl(+) Amp
KpnI SacI
A  pKS-ABC
B  pKS-nptII
lac
prom
KpnI SacI
NPTII
b-galactosidase
fl(+) Amp
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prom Multiple cloning site
b-galactosidase
fl(+) Amp
KpnI SacI
C  pKS
2178 bp
800 bp 
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Figure 2.  Effect of ampicillin (A) and kanamycin (B) on the growth of the soilborne 
bacteria, Variovorax, Acidovorax and Rahnella. Optical densities were measured at 630 
nm to determine the growth of Variovorax, Acidovorax and Rahnella incubated at 30°C 
in 96 well microtiter plates containing 199 µl LB and serially diluted 0 to 100 mg L-1 
kanamycin. 
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Plasmid                  pKS                            pKS-ABC                     pKS-nptII  
Antibiotic   G418            Kan            G418            Kan            G418          Kan 
   ____  ____  ____  ____  ____  ____  ____  ____  ____  ____  ____  ____ 
mg L-1     0     6.25      0     12.5      0     6.25       0    12.5      0      6.25     0      12.5 
Rep        A  B  A  B   A  B  A  B   A  B   A  B   A  B  A  B   A  B   A  B  A  B  A  B 
 
 
Figure 3.  A check of quality and quantity of RNA using a 1% agarose gel prior to 
running the formaldehyde gel.  Each lane represents 2 µg total RNA obtained from E. 
coli transformed with either pKS, pKS-nptII  or pKS-ABC and incubated in varying 
concentrations (0, 6.25 or 12.5 mg L-1) of antibiotics (G418 or kanamycin) in duplicate 
(A, B). The name of each sample is labeled above the panel.  M=marker.  
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Figure 4.  Plasmids (1=pKS-nptII, 2=pKS-ABC, and 3=pKS) were digested with KpnI 
and SacI and ran on a 1% agarose gel.  Bands were excised, gel purified and were used in 
the creation of probes for the northern blotting.  M=marker.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M                1         2          3 
pKS (~2800 bp)
pKS-ABC (2178 bp) 
pKS-nptII (~800 bp) 
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Figure 5.  Quality control check of probes used in the northern blot.  Probes, 1=nptII and 
2=ABC, at 200 ng were ran on a 1% agarose gel.  M=marker. 
 
 
 
 
 
 
 
   M    1      2             M 
pKS-nptII (~800 bp) 
pKS-ABC (2178 bp) 
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Figure 6.  Effect of media type (Mueller-Hinton broth) on the growth of E. coli DH5α.  
Optical densities (measured at 630 nm) of E. coli DH5α transformed (pKS-ABC, pKS-
nptII or pKS) incubated at 37°C in 96 well microtiter plates containing 199 µl Mueller-
Hinton broth, induced using 1 mM IPTG and serially diluted 0 to 400 mg L-1 kanamycin.   
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Figure 7.  Optical densities (measured at 630 nm) of E. coli DH5α transformed (pKS-
ABC (n=12), pKS-nptII (n=12) or pKS (n=6)) incubated at 37°C in 96 well microtiter 
plates containing 199 µl LB, induced using 1 mM IPTG and serially diluted 0 to 400 mg 
L-1 kanamycin.  Data were analyzed by ANOVA using the general linear model, and 
Duncan’s Multiple Range test was used to compare treatment mean values when 
significant differences (at the 0.05 probability level) were found.  Minimal concentration 
in which significant difference between pKS-nptII and pKS-ABC occurs is symbolized 
with an asterisk. Error bars indicate standard error. 
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Figure 8.  Optical densities (measured at 630 nm) of E. coli DH5α transformed (pKS-
ABC (n=12), pKS-nptII (n=12) or pKS (n=6)) incubated at 37°C in 96 well microtiter 
plates containing 199 µl LB, induced using 1 mM IPTG and serially diluted 0 to 100 mg 
L-1 geneticin (G418).  Data were analyzed by ANOVA using the general linear model, 
and Duncan’s Multiple Range test was used to compare treatment mean values when 
significant differences (at the 0.05 probability level) were found.  Minimal concentration 
in which significant difference between pKS-nptII and pKS-ABC occurs is symbolized 
with an asterisk. Error bars indicate standard error. 
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Figure 9.  Optical densities (measured at 630 nm) of E. coli DH5α transformed (pKS-
ABC (n=12), pKS-nptII (n=12) or pKS (n=6)) incubated at 37°C in 96 well microtiter 
plates containing 199 µl LB, induced using 1 mM IPTG and serially diluted 0 to 400 mg 
L-1 gentamicin.  Data were analyzed by ANOVA using the general linear model.  No 
significant differences (at the 0.05 probability level) were found between treatments.  
Error bars indicate standard error. 
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Figure 10.  Products following reverse transcription PCR of pKS-nptII (A) and pKS-
ABC (B) grown at 0 and 12.5 mg L-1 kanamycin and ran on a 1% agarose gel.    
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           pKS-nptII Kan          pKS     pKS-ABC Kan               pKS 
         ______________       ________    ______________        ________ 
(mg/ml)          0           12.5            0    12.5                        0            12.5            0    12.5            
Replicate    A     B     A     B           A     B      A     B              
                
 
                  
 
Figure 11.  Each lane represents 2 µg total RNA obtained from E. coli transformed with 
either pKS-nptII  (panel A), pKS-ABC (panel B) or pKS (negative control) and incubated 
in varying concentrations (0 or 12.5 mg L-1) of kanamycin in duplicate (A, B). The blots 
were hybridized with a [32-P] radiolabelled nptII or ABC probe respectively. Expected 
band sizes were 0.8 kb and 2.2 kb for pKS-nptII and pKS-ABC respectively.  The name 
of each sample is labeled above the panel. 
 
 
 
 
 
 
 
 
 
A B
 68
Atwbc19
Cytosol
Cell wall
???
Sequestration? 
Extruded via plasma 
membrane
Kanamycin 3’-
phosphate + ADP 
Aminoglycoside 3’-
phosphotransferase
ATP
ATP ADP + Pi
ATPADP + Pi
Kanamycin
Kanamycin sulfate
VacuoleA
 
Cell wall
Cytoplasmic membrane
Cytoplasm
Nucleoid
Kanamycin
ATP ADP + Pi
Atwbc19
ATP ADP + Pi
Enlarged view
 
Figure 12.  Possible modes-of-action of Atwbc19, an Arabidopsis thaliana gene shown to 
confer kanamycin resistance, in plants(A) (Adapted from Rea 2005) and not in bacteria 
(B).  Bacteria have no mechanism of eliminating the kanamycin; therefore, the bacterial 
membranes become overwhelmed and the cells become lysed, leading to the death of the 
bacteria.  Atwbc19 may be targeted to the bacterial membrane and aid in some removal of 
kanamycin. 
B 
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Table 1.  Selectable marker genes (ARMs and herbicides) utilized in transgenic plants in 
the United States (adapted from Miki and McHugh 2004).  
Enzymes Gene Selection 
   
ARMs   
     Αcetyl transferase sat3 Streptothricin 
     Αminoglycoside-3”-adenyl transferase aadA Spectinomycin 
     β-lactamase bla Ampicillin 
     Bleomycin resistance Ble Bleomycin, 
phleomycin 
     Chloramphenicol acetyltransferase cat Chloramphenicol 
     Dihydropteroate synthase sul1 Sulfonamides 
     Hygromycin phosphotransferase hph Hygromycin B 
     Neomycin phosphotransferase neo,nptII Neomycin, kanamycin 
     Streptomycin phosphotransferase SPT Spectomycin, 
spectinomycin 
   
Chemical   
     Acetolactate synthase csr1-1 Sulfonylureas 
     Acetolactate synthase csr1-2 Imidazolinones 
     β-glucuronidase   
     Bromoxinil nitrilase Bnx Oxynils 
     Cyanamide hydratase cah Cyanamide 
     5-enolpyruvylshikimate-3-phosphate   
          synthase 
EPSP synthase, 
aroA 
Glyphosate 
     Glutamate-1-semialdehyde  
          aminotransferase 
hemL Gabaculine 
     Glyphosate oxidoreductase cp4 epsps, gox Glyphosate 
     Phosphinothricin acetyl transferase pat, bar Bialaphos, glufosinate, 
PPT 
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